Gender and long-term metabolic toxicities from antiretroviral therapy in HIV-1 infected persons

Mohamed Rachid Boulassel, Rosa Morales, Tanya Murphy, Richard G. Lalonde, Marina B. Klein

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Gender differences in a large population-based cohort of HIV-1 infected patients (245 women and 723 men) were examined with respect to the incidence of metabolic and morphologic alterations after initiation of highly active antiretroviral therapy (HAART). Patients initiated HAART between January 1996 and December 2003. The outcome measures were the incidence of hyperglycemia, hypercholesterolemia, symptomatic lactic acidosis, treatment-limiting lipodystrophy, and hypersensitivity reaction. Cox proportional hazards models were used to estimate the crude and adjusted hazard ratios of reaching the endpoints for exposures and covariates. Women were younger than men (35 ± 9.8 vs. 40 ± 8.2 years, P< 0.001) and more frequently from Haiti or Africa (59%), whereas 76% of men were Canadian-born. Type of initial HAART regimen did not differ between women and men. There were no gender differences in the overall incidence of hyperglycemia, hypercholesterolemia, or treatment-limiting lipodystrophy, even after adjusting for age, CD4 cell count, viral load, time since HIV diagnosis, history of AIDS-defining illness and year of HAART initiation. In contrast, women had significantly higher risk of developing lactic acidosis than men (P = 0.0009). Hypersensitivity reactions were also more frequent in women than men (adjusted hazard ratio = 4.4 (95% CI: 2.1-9.3)). Collectively, these data suggest that metabolic toxicities after HAART do not differ by gender but that lactic acidosis and hypersensitivity reactions are more frequent in women than men.

Original languageEnglish
Pages (from-to)1158-1163
Number of pages6
JournalJournal of Medical Virology
Volume78
Issue number9
DOIs
Publication statusPublished - Sep 2006

Fingerprint

HIV-1
Highly Active Antiretroviral Therapy
Lactic Acidosis
Lipodystrophy
Hypercholesterolemia
Hyperglycemia
Therapeutics
Incidence
Hypersensitivity
Milk Hypersensitivity
Haiti
CD4 Lymphocyte Count
Viral Load
Proportional Hazards Models
Acquired Immunodeficiency Syndrome
Outcome Assessment (Health Care)
HIV
Population

Keywords

  • Gender
  • HAART
  • Hypercholesterolemia
  • Hyperglycemia
  • Hypersensitivity reaction

ASJC Scopus subject areas

  • Infectious Diseases
  • Virology

Cite this

Gender and long-term metabolic toxicities from antiretroviral therapy in HIV-1 infected persons. / Boulassel, Mohamed Rachid; Morales, Rosa; Murphy, Tanya; Lalonde, Richard G.; Klein, Marina B.

In: Journal of Medical Virology, Vol. 78, No. 9, 09.2006, p. 1158-1163.

Research output: Contribution to journalArticle

Boulassel, Mohamed Rachid ; Morales, Rosa ; Murphy, Tanya ; Lalonde, Richard G. ; Klein, Marina B. / Gender and long-term metabolic toxicities from antiretroviral therapy in HIV-1 infected persons. In: Journal of Medical Virology. 2006 ; Vol. 78, No. 9. pp. 1158-1163.
@article{23c77c28c57d484aa17978aaea536bbe,
title = "Gender and long-term metabolic toxicities from antiretroviral therapy in HIV-1 infected persons",
abstract = "Gender differences in a large population-based cohort of HIV-1 infected patients (245 women and 723 men) were examined with respect to the incidence of metabolic and morphologic alterations after initiation of highly active antiretroviral therapy (HAART). Patients initiated HAART between January 1996 and December 2003. The outcome measures were the incidence of hyperglycemia, hypercholesterolemia, symptomatic lactic acidosis, treatment-limiting lipodystrophy, and hypersensitivity reaction. Cox proportional hazards models were used to estimate the crude and adjusted hazard ratios of reaching the endpoints for exposures and covariates. Women were younger than men (35 ± 9.8 vs. 40 ± 8.2 years, P< 0.001) and more frequently from Haiti or Africa (59{\%}), whereas 76{\%} of men were Canadian-born. Type of initial HAART regimen did not differ between women and men. There were no gender differences in the overall incidence of hyperglycemia, hypercholesterolemia, or treatment-limiting lipodystrophy, even after adjusting for age, CD4 cell count, viral load, time since HIV diagnosis, history of AIDS-defining illness and year of HAART initiation. In contrast, women had significantly higher risk of developing lactic acidosis than men (P = 0.0009). Hypersensitivity reactions were also more frequent in women than men (adjusted hazard ratio = 4.4 (95{\%} CI: 2.1-9.3)). Collectively, these data suggest that metabolic toxicities after HAART do not differ by gender but that lactic acidosis and hypersensitivity reactions are more frequent in women than men.",
keywords = "Gender, HAART, Hypercholesterolemia, Hyperglycemia, Hypersensitivity reaction",
author = "Boulassel, {Mohamed Rachid} and Rosa Morales and Tanya Murphy and Lalonde, {Richard G.} and Klein, {Marina B.}",
year = "2006",
month = "9",
doi = "10.1002/jmv.20676",
language = "English",
volume = "78",
pages = "1158--1163",
journal = "Journal of Medical Virology",
issn = "0146-6615",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - Gender and long-term metabolic toxicities from antiretroviral therapy in HIV-1 infected persons

AU - Boulassel, Mohamed Rachid

AU - Morales, Rosa

AU - Murphy, Tanya

AU - Lalonde, Richard G.

AU - Klein, Marina B.

PY - 2006/9

Y1 - 2006/9

N2 - Gender differences in a large population-based cohort of HIV-1 infected patients (245 women and 723 men) were examined with respect to the incidence of metabolic and morphologic alterations after initiation of highly active antiretroviral therapy (HAART). Patients initiated HAART between January 1996 and December 2003. The outcome measures were the incidence of hyperglycemia, hypercholesterolemia, symptomatic lactic acidosis, treatment-limiting lipodystrophy, and hypersensitivity reaction. Cox proportional hazards models were used to estimate the crude and adjusted hazard ratios of reaching the endpoints for exposures and covariates. Women were younger than men (35 ± 9.8 vs. 40 ± 8.2 years, P< 0.001) and more frequently from Haiti or Africa (59%), whereas 76% of men were Canadian-born. Type of initial HAART regimen did not differ between women and men. There were no gender differences in the overall incidence of hyperglycemia, hypercholesterolemia, or treatment-limiting lipodystrophy, even after adjusting for age, CD4 cell count, viral load, time since HIV diagnosis, history of AIDS-defining illness and year of HAART initiation. In contrast, women had significantly higher risk of developing lactic acidosis than men (P = 0.0009). Hypersensitivity reactions were also more frequent in women than men (adjusted hazard ratio = 4.4 (95% CI: 2.1-9.3)). Collectively, these data suggest that metabolic toxicities after HAART do not differ by gender but that lactic acidosis and hypersensitivity reactions are more frequent in women than men.

AB - Gender differences in a large population-based cohort of HIV-1 infected patients (245 women and 723 men) were examined with respect to the incidence of metabolic and morphologic alterations after initiation of highly active antiretroviral therapy (HAART). Patients initiated HAART between January 1996 and December 2003. The outcome measures were the incidence of hyperglycemia, hypercholesterolemia, symptomatic lactic acidosis, treatment-limiting lipodystrophy, and hypersensitivity reaction. Cox proportional hazards models were used to estimate the crude and adjusted hazard ratios of reaching the endpoints for exposures and covariates. Women were younger than men (35 ± 9.8 vs. 40 ± 8.2 years, P< 0.001) and more frequently from Haiti or Africa (59%), whereas 76% of men were Canadian-born. Type of initial HAART regimen did not differ between women and men. There were no gender differences in the overall incidence of hyperglycemia, hypercholesterolemia, or treatment-limiting lipodystrophy, even after adjusting for age, CD4 cell count, viral load, time since HIV diagnosis, history of AIDS-defining illness and year of HAART initiation. In contrast, women had significantly higher risk of developing lactic acidosis than men (P = 0.0009). Hypersensitivity reactions were also more frequent in women than men (adjusted hazard ratio = 4.4 (95% CI: 2.1-9.3)). Collectively, these data suggest that metabolic toxicities after HAART do not differ by gender but that lactic acidosis and hypersensitivity reactions are more frequent in women than men.

KW - Gender

KW - HAART

KW - Hypercholesterolemia

KW - Hyperglycemia

KW - Hypersensitivity reaction

UR - http://www.scopus.com/inward/record.url?scp=33746835718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746835718&partnerID=8YFLogxK

U2 - 10.1002/jmv.20676

DO - 10.1002/jmv.20676

M3 - Article

C2 - 16847953

AN - SCOPUS:33746835718

VL - 78

SP - 1158

EP - 1163

JO - Journal of Medical Virology

JF - Journal of Medical Virology

SN - 0146-6615

IS - 9

ER -